How can the Impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? design of a conceptual framework;Wie kann der Impact von Health Technology Assessment (HTA) im österreichischen Gesundheitssystem ermittelt werden? Die Entwicklung eines Analyseinstruments

Gesundheitswesen

Volumn 74, Issue 4, 2012, Pages 257-265

  Schumacher, I ^a   Zechmeister, I ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Austria; framework; HTA Impact; research evaluation; review

Indexed keywords

ARTICLE; AUSTRIA; BIOMEDICAL TECHNOLOGY ASSESSMENT; HEALTH CARE QUALITY; MEDICAL TECHNOLOGY; METHODOLOGY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH;

AUSTRIA; BIOMEDICAL TECHNOLOGY; MODELS, ORGANIZATIONAL; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84859920636     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0030-1270503     Document Type: Review

References (26)

1. Perleth M, Busse R, Gerhardus A et al,. Health Technology Assessment. Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. Berlin Medizinisch Wissenschaftliche Verlagsgesellschaft 2008
2. Gerhardus A. Konzepte und Methoden zur Erhebung des Einflusses von HTA-Berichten auf das Gesundheitswesen. Magisterarbeit an der Medizinischen Hochschule Hannover 2005
3. Axelsson S, Helgason AR, Lund KE et al,. Disseminating evidence from Health Technology Assessment: the case of tobacco prevention. International Journal of Technology Assessment in Health Care 2006 22 500-505 (Pubitemid 44622971)
4. Alanen S, Johannala-Kemppainen R, Ijäs JJ et al,. Evaluation of current care effectiveness: a survey of hypertension guideline implementation in Finnish health centres. Scandinavian Journal of Primary Health Care 2007 25 232-236 (Pubitemid 350179033)
5. Dietrich ES. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England. International Journal of Technology Assessment in Health Care 2009 25 262-271
6. Sepulveda B, Horowicz-Mehler N, Doyle JJ. The effects of NICE HTAs on prescription volume, average retail price and average out-of-pocket costs of drugs deemed medically necessary for medicare part D reimbursement in the United States. Value in Health 2008 11 A376-A377
7. Kolasa K. The role of HTA agency in drug reimbursement decision-making process in Poland (HTA IMPT). Value in Health 2009 12 A251
8. White J. The rapid adoption of Health Technology Assessment in middle income countries - what influence does it have on pharmaceutical reimbursement. Results from a survey of health care decision-makers in 11 countries. Value in Health 2009 12 A245
9. Gagnon MP, Sanchez E, Pons JM. From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations. Implementation science 2006 1 8
10. Blancquaert I. Managing partnerships and impact on decision-making: the example of Health Technology Assessment in genetics. Community Genetics 2006 9 27-33 (Pubitemid 43289515)
11. Oortwijn WJ, Hanney SR, Ligtvoet A et al,. Assessing the impact of Health Technology Assessment in The Netherlands. International Journal of Technology Assessment in Health Care 2008 24 259-269 (Pubitemid 351950161)
12. Raftery J, Hanney S, Green C et al,. Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the payback approach. International Journal of Technology Assessment in Health Care 2009 25 1-5
13. McGregor M, Brophy JM. End-user involvement in Health Technology Assessment (HTA) development: a way to increase impact. International Journal of Technology Assessment in Health Care 2005 21 263-267 (Pubitemid 40656557)
14. Gerhardus A, Dorendorf E, R ttingen J-A et al,. What are the effects of HTA reports on the health system? Evidence from the research literature. Health Technology Assessment and Health Policy-Making in Europe: Current status, challenges and potential 2008 109-136
15. Hailey D. A preliminary survey on the influence of rapid Health Technology Assessments. International Journal of Technology Assessment in Health Care 2009 25 415-418
16. Hanney S, Buxton M, Green C et al,. An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technology Assessment (Winchester, England) 2007 11 iii-iv
17. Oliver A, Mossialos E, Robinson R et al,. Health Technology Assessment and its influence on health-care priority setting. International Journal of Technology Assessment in Health Care 2004 20 1-10 (Pubitemid 38656956)
18. Gallego G, van Gool K, Kelleher D et al,. Resource allocation and Health Technology Assessment in Australia: views from the local level. International Journal of Technology Assessment in Health Care 2009 25 134-140
19. Gagnon MP, Sanchez E, Pons JM et al,. Integration of Health Technology Assessment recommendations into organizational and clinical practice: a case study in Catalonia. International Journal of Technology Assessment in Health Care 2006 22 169-176
20. Bodeau-Livinec F, Simon E, Montagnier-Petrissans C et al,. Impact of CEDIT recommendations: an example of Health Technology Assessment in a hospital network. International Journal of Technology Assessment in Health Care 2006 22 161-168
21. Rubinstein A, Beliz n M, Discacciati V. Are economic evaluations and Health Technology Assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crises. International Journal of Technology Assessment in Health Care 2007 23 169-176 (Pubitemid 46642724)
22. Buxton M, Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy 1996 1 35-43
23. Gerhardus A. Die Rolle von HTA-Berichten im deutschen Gesundheitswesen. Brauchen wir Impactziele? Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2006 49 233-240 (Pubitemid 43880412)
24. Poortvliet E, Vijfvinkel D, Vennekens A et al,. Study into the impact of the Belgian Health Care Knowledge Centre. 2010
25. Weiss CH. The many meanings of research utilization. Public Administration Review 1979 39 426-431
26. Antony K, Fröschl B, Rosian-Schikuta I et al,. Health Technology Assessment. Einsatz und Bedarf in Österreich und Implikationen für die Verankerung in Österreich. Im Auftrag des Bundesministeriums für Gesundheit: Gesundheit Österreich GmbH Geschäftsbereich BIQS 2009